Cargando…
Metabolomics-Based Discovery of Diagnostic Biomarkers for Onchocerciasis
BACKGROUND: Development of robust, sensitive, and reproducible diagnostic tests for understanding the epidemiology of neglected tropical diseases is an integral aspect of the success of worldwide control and elimination programs. In the treatment of onchocerciasis, clinical diagnostics that can func...
Autores principales: | Denery, Judith R., Nunes, Ashlee A. K., Hixon, Mark S., Dickerson, Tobin J., Janda, Kim D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950146/ https://www.ncbi.nlm.nih.gov/pubmed/20957145 http://dx.doi.org/10.1371/journal.pntd.0000834 |
Ejemplares similares
-
Noninvasive Urine Biomarker Lateral Flow Immunoassay
for Monitoring Active Onchocerciasis
por: Shirey, Ryan J., et al.
Publicado: (2018) -
Validation of onchocerciasis biomarker N-acetyltyramine-O-glucuronide (NATOG)
por: Globisch, Daniel, et al.
Publicado: (2017) -
Diagnostics for onchocerciasis in the era of elimination
por: Unnasch, Thomas R, et al.
Publicado: (2018) -
Metabolomics and Biomarkers for Drug Discovery
por: Yeung, Pollen K.
Publicado: (2018) -
Salivary Metabolomics: From Diagnostic Biomarker Discovery to Investigating Biological Function
por: Gardner, Alexander, et al.
Publicado: (2020)